ECOM cardiac output for Hemodynamic Monitoring

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Hemodynamic MonitoringECOM cardiac output - Device
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will compare the accuracy of a new cardiac output monitor to two existing ones.

Treatment Effectiveness

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 6 months.

6 months.
Comparison of ECOM Plus impedance and thermal dilution cardiac output measurements

Trial Safety

Trial Design

1 Treatment Group

Single Group Assignment
1 of 1

Experimental Treatment

110 Total Participants · 1 Treatment Group

Primary Treatment: ECOM cardiac output · No Placebo Group · N/A

Single Group Assignment
Device
Experimental Group · 1 Intervention: ECOM cardiac output · Intervention Types: Device

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 6 months.

Who is running the clinical trial?

ECOM Medical, Inc.Lead Sponsor
Arthur Wallace, MDPrincipal InvestigatorVA San Francisco

Eligibility Criteria

Age 18+ · All Participants · 2 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you: